Stay updated with breaking news from Patrick Aloy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the race to to find a cure, scientists are rushing to release their study results. There are dangers in skipping the standard peer-review procedures, but they may be outweighed by the benefits.
Targeted protein degradation uses different types of "degrading" drugs (degraders) to force proximity between a target protein (for example, a mutated protein that contributes to the development of a disease) and the cellular machinery that directs protein degradation.
This week, the Institute for Research in Biomedicine (IRB Barcelona) and the BBVA Foundation are hosting the 39th Barcelona BioMed Conference—an event in which leading figures can exchange ideas and discuss the latest advances in the field of proximity induction-based pharmacology. The “Proximity-inducing pharmacology: Targeted protein degradation and beyond” conference, co-organised by Dr. Cristina Mayor-Ruiz, from IRB Barcelona, and Dr. Georg E. Winter, from the CeMM Research Center for Molecular Medicine in Vienna (Austria), is being held in Barcelona between 22 and 24 May. Dr. May...
Scientists at IRB Barcelona, have developed the Bioteque, a computational tool to harmonize, integrate and simplify biological data.